Does quetiapine cause QT interval prolongation or tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Quetiapine and Cardiac Effects

Yes, quetiapine does cause QT prolongation, though the degree is modest (mean 6 ms), and it can also cause tachycardia, particularly in overdose situations. 1

QT Prolongation Risk Profile

Quetiapine is classified as an antipsychotic with low-to-moderate QT prolonging potential. According to the 2016 Pediatrics guidelines, quetiapine causes a mean QT prolongation of approximately 6 milliseconds at therapeutic doses 1. This places it in the lower-middle range among antipsychotics—significantly less than thioridazine (25-30 ms) or ziprasidone (5-22 ms), but more than aripiprazole (0 ms) or olanzapine (2 ms).

The FDA label explicitly states that quetiapine was not associated with persistent QT increases in clinical trials, but postmarketing cases of QT prolongation have been reported, particularly in overdose situations, patients with concomitant illness, and those taking other QT-prolonging medications 2.

Clinical Significance

The 2023 Canadian Cardiovascular Society guidelines classify antipsychotics/antidepressants as one of the common drug classes causing acquired long QT syndrome (aLQTS), using the mnemonic "remember the anti's" 3. However, the actual risk of torsades de pointes (TdP) with quetiapine appears to be overstated based on recent evidence 4.

Recent research demonstrates:

  • In acute quetiapine overdose, QT prolongation occurs but TdP is rare 4
  • A 2024 multicenter study found 13% of quetiapine users developed severe QT prolongation (QTc >500 ms or increase >60 ms), with associated increased risk of ventricular arrhythmias (OR 2.84) and sudden cardiac death (OR 2.29) 5
  • A 2018 ICU study showed only 13.6% of critically ill patients on quetiapine developed QTc prolongation >60 ms, with no cases of TdP 6

Tachycardia

Quetiapine is commonly associated with tachycardia, particularly in overdose situations 7. The research literature consistently reports tachycardia as a frequent finding in quetiapine overdose, along with hypotension and altered mental status 7, 8.

Interestingly, bradycardia (not tachycardia) was identified as a predictor of QT prolongation in acute quetiapine poisoning 8, suggesting different cardiac effects may occur depending on dose and clinical context.

Risk Stratification and Management

When to Obtain ECG

The FDA label and guidelines recommend avoiding quetiapine in specific high-risk circumstances 2:

  1. History of cardiac arrhythmias (especially bradycardia)
  2. Electrolyte abnormalities (hypokalemia, hypomagnesemia)
  3. Concomitant use of other QT-prolonging drugs (Class IA/III antiarrhythmics, other antipsychotics like ziprasidone/thioridazine, certain antibiotics)
  4. Congenital long QT syndrome
  5. Cardiovascular disease, heart failure, cardiac hypertrophy
  6. Elderly patients
  7. Women (higher risk for aLQTS) 3

Practical Monitoring Approach

Based on the 2023 Canadian guidelines 3:

  • Routine ECG monitoring is NOT needed for otherwise healthy patients starting quetiapine without other risk factors
  • Consider baseline ECG if any of the above risk factors are present
  • Monitor electrolytes and renal function, especially if patient is on diuretics
  • Risk increases when QTc exceeds 500 ms or increases by >60-70 ms from baseline
  • Check www.crediblemeds.org before adding other medications

Key Clinical Pitfalls

The most important caveat: avoid combining quetiapine with other QT-prolonging medications 2. The FDA label specifically warns against combining with:

  • Class IA antiarrhythmics (quinidine, procainamide)
  • Class III antiarrhythmics (amiodarone, sotalol)
  • Other antipsychotics (ziprasidone, chlorpromazine, thioridazine)
  • Certain antibiotics (gatifloxacin, moxifloxacin)
  • Methadone, pentamidine

When adding antibiotics to a patient on quetiapine, choose penicillins or cephalosporins rather than macrolides or fluoroquinolones 3.

Overdose Management

For acute quetiapine overdose, the 2025 systematic review does NOT recommend routine continuous cardiac monitoring 4. A screening ECG is suggested, but the risk of TdP appears overstated compared to other antipsychotics like amisulpride, thioridazine, or ziprasidone.

However, patients with quetiapine overdose who develop bradycardia, hypotension, or have baseline risk factors warrant closer monitoring 8, 5.

References

Related Questions

How should I manage a patient with a corrected QT interval of 453 ms who is taking quetiapine, hydroxyzine, and sertraline?
Can quetiapine (Seroquel) cause premature ventricular or atrial contractions (extrasystoles), and how should they be managed?
Does quetiapine prolong the PR interval on an electrocardiogram?
In a young male patient taking hydroxyzine, sertraline, and quetiapine with a QTc of 453 ms, normal electrolytes and pending magnesium results, should hydroxyzine be discontinued immediately?
What are the risks and precautions for co‑administering ciprofloxacin and quetiapine due to their potential QT‑interval prolongation?
In an athlete with an acute grade II or III muscle tear who has not improved after 2–3 weeks of rest, compression, NSAIDs, and progressive loading, and who has no contraindications such as infection, anticoagulation, platelet disorder, or severe systemic illness, what is the role of platelet‑rich plasma (PRP) in management?
If a renal stone is not visualized on plain X‑ray, should we proceed directly with extracorporeal shock wave lithotripsy (ESWL) or first perform an ultrasound examination?
What Hounsfield unit (HU) value is optimal for extracorporeal shock wave lithotripsy (ESWL)?
Can the CAPOX regimen be given using a peripheral intravenous line, or is a central venous access device (port) required?
After stopping Latuda (lurasidone) 17 days ago, when will I be able to nap again?
In a tracheostomy‑ and ventilator‑dependent patient on day 7 of piperacillin‑tazobactam (Zosyn) for sepsis, who is afebrile, hemodynamically stable, has no new ventilator requirements, a chest X‑ray without consolidation, low‑count urine gram‑negative rods, and persistent leukocytosis, should I complete the piperacillin‑tazobactam course without adding other antibiotics and obtain blood cultures now?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.